134 related articles for article (PubMed ID: 7583678)
21. Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron.
Zaleska MM; Floyd RA
Neurochem Res; 1985 Mar; 10(3):397-410. PubMed ID: 4000395
[TBL] [Abstract][Full Text] [Related]
22. Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer disease.
Andorn AC; Britton RS; Bacon BR; Kalaria RN
Mol Chem Neuropathol; 1998 Jan; 33(1):15-26. PubMed ID: 9493173
[TBL] [Abstract][Full Text] [Related]
23. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical.
Andorn AC; Britton RS; Bacon BR
J Neurochem; 1996 Aug; 67(2):717-22. PubMed ID: 8764600
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of catalase in mesencephalic cultures by L-DOPA and dopamine.
Han SK; Cohen G
Neurochem Int; 1996 Dec; 29(6):645-9. PubMed ID: 9113132
[TBL] [Abstract][Full Text] [Related]
25. Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.
Sziráki I; Mohanakumar KP; Rauhala P; Kim HG; Yeh KJ; Chiueh CC
Neuroscience; 1998 Aug; 85(4):1101-11. PubMed ID: 9681949
[TBL] [Abstract][Full Text] [Related]
26. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
27. Effect of intracellular iron loading on lipid peroxidation of brain slices.
Oubidar M; Boquillon M; Marie C; Bouvier C; Beley A; Bralet J
Free Radic Biol Med; 1996; 21(6):763-9. PubMed ID: 8902522
[TBL] [Abstract][Full Text] [Related]
28. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
29. A possible mechanism for initiation of lipid peroxidation by ascorbate in rat liver microsomes.
Casalino E; Sblano C; Landriscina C
Int J Biochem Cell Biol; 1996 Feb; 28(2):137-49. PubMed ID: 8729001
[TBL] [Abstract][Full Text] [Related]
30. In vitro influence of ascorbate on lipid peroxidation in rat testis and heart microsomes.
Melin AM; Peuchant E; Perromat A; Clerc M
Mol Cell Biochem; 1997 Apr; 169(1-2):171-6. PubMed ID: 9089645
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
32. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
Hamazaki S; Okada S; Li JL; Toyokuni S; Midorikawa O
Arch Biochem Biophys; 1989 Jul; 272(1):10-7. PubMed ID: 2500058
[TBL] [Abstract][Full Text] [Related]
33. Dopamine and DOPA cause release of iron from ferritin and lipid peroxidation of liposomes.
Tanaka M; Yoshida T; Okamoto K; Hirai S
Neuroreport; 1999 Jun; 10(9):1883-7. PubMed ID: 10501526
[TBL] [Abstract][Full Text] [Related]
34. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
Sarre S; Vandeneede D; Ebinger G; Michotte Y
J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592
[TBL] [Abstract][Full Text] [Related]
35. Importance of two iron-reducing systems in lipid peroxidation of rat brain: implications for oxygen toxicity in the central nervous system.
Arai H; Kogure K; Sugioka K; Nakano M
Biochem Int; 1987 Apr; 14(4):741-9. PubMed ID: 2839181
[TBL] [Abstract][Full Text] [Related]
36. Autoxidation of rat brain homogenate: evidence for spontaneous lipid peroxidation. Comparison with the characteristics of Fe2+- and ascorbic acid-stimulated lipid peroxidation.
Barrier L; Page G; Fauconneau B; Juin F; Tallineau C
Free Radic Res; 1998 Apr; 28(4):411-22. PubMed ID: 9684986
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
38. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
Fisher A; Biggs CS; Eradiri O; Starr MS
Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
[TBL] [Abstract][Full Text] [Related]
39. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Lees AJ; Tolosa E; Olanow CW
Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
[TBL] [Abstract][Full Text] [Related]
40. Prooxidant role of histidine in hypoxic stressed mice and Fe(3+)-induced lipid peroxidation.
Paul VN; Chopra K; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):551-5. PubMed ID: 11196342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
